Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.78% | -2.94% | 0.15% | -7.80% | 20.96% |
| Total Depreciation and Amortization | 31.25% | -4.43% | 30.13% | -41.04% | -28.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00% | 123.08% | 6,000.00% | 545.61% | -100.35% |
| Change in Net Operating Assets | 674.83% | -55.68% | -40.74% | 123.16% | -169.72% |
| Cash from Operations | 27.00% | -34.12% | -0.25% | 36.89% | -7.27% |
| Capital Expenditure | -- | -- | -15,690.91% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -15,690.91% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00% | -10.00% | 0.00% | 99.33% | 99.95% |
| Issuance of Common Stock | 120.97% | -- | -- | -100.00% | -55.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.78% | -- | -- | -- | 59.00% |
| Cash from Financing | 123.50% | 12,510.00% | 285,576.92% | 99.32% | -55.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 345.70% | -24.84% | 243.25% | 40.90% | -75.41% |